New Study Associates Ozempic Weight-Loss Medication With Vision Loss Risks
Exploring the Vision Risks Linked to a Widely Used Diabetes and Weight Loss Drug Imagine this: a medication so effective at managing diabetes and aiding weight loss that it quickly becomes a household name Now, picture the concern when studies suggest it could harm your sight This isn't a plot from a sci-fi novel but the reality for patients taking semaglutide, a medication marketed under the names Ozempic and Wegovy The Research Findings A recent investigation by the prestigious team at Mass Eye and Ear, affiliated with Harvard, highlights a worrying link between semaglutide and a rare vision condition known as nonarteritic anterior ischemic optic neuropathy (NAION) The study shines a light on the fact that patients using this medication may face a higher risk of developing NAION, potentially leading to vision loss...
Lire la suite